Windshire Seda Partnership for U.S. Biotech Growth

Windshire Consulting is pleased to continue our collaboration with Seda, supporting their expansion into the U.S. through enhanced market access and strategic engagement.

Seda is a specialized, science-first drug product CRDMO dedicated to helping biotech companies solve complex therapeutic challenges.

Through this partnership, Windshire enables clients to access Seda’s unique integrated, science-led development approach, seamlessly connecting:
Modeling → Formulation → Development → GMP Clinical Manufacturing

Learn more about Seda here.

At Windshire, whether supporting strategic planning, development partner selection, CMC execution, commercialization strategy, or U.S. market expansion, our goal remains the same: To help guide clients to expand their businesses, make better decisions earlier in asset development, reduce development risk, and accelerate progress toward key milestones. We look forward to supporting innovative biotech and service focused companies as they advance the next generation of therapies.